The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes.
Open accessAbstract
A collaborative study of screening programmes in eight countries was performed to estimate the risks of cervical cancer associated with different screening policies. Most of the data came from centrally organised screening programmes. Relative protection was higher in women who had had two or more negative results of screening tests than in those who had had only one negative smear, particularly in the first five years after the last test. There was little difference in the protection afforded by screening every year compared with every three years, but screening only once every five or 10 years offered appreciably less protection. The age of the women did not affect the sensitivity of the test or the sojourn time of the disease (the length of the detectable preclinical phase during which abnormal cytology could be picked up if a smear were taken); invasive cancer in women under 25 was rare. Centrally organised screening programmes were more effective than uncoordinated screening. Screening programmes should be aimed principally at women aged 35-60 but should start some years before the age of 35, and the intervals between screening should be three years or less.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Day, N. E., & Walter, S. D. (1984) · Biometrics · doi:10.2307/2530739 · Cited by 263
CERVICAL CANCER DETECTION IN BRITISH COLUMBIA: A Progress Report*
Fidler, H. K., Boyes, D. A., & Worth, A. J. (1968) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1968.tb00136.x · Cited by 220
A cohort study of cervical cancer screening in British Columbia.
Boyes, D. A., Morrison, B., Knox, E. G., Draper, G. J., & Miller, A. B. (1982) · PubMed · Cited by 120
Papanicolaou Smear Screening and Cervical Cancer
Stenkvist, B. (1984) · JAMA · doi:10.1001/jama.1984.03350110023023 · Cited by 69
Screening for Cancer of the Uterine Cervix in Iceland 1965–1978
Jóhannesson, G., Geirsson, G., Day, N., et al. (1982) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348209156556 · Cited by 58
Cited by
Screening for cervical cancer: U.S. preventive services Task force recommendation statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-12-201206190-00424 · Cited by 1,049
Eddy, D. M. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-214 · Cited by 837
The cervical cancer epidemic that screening has prevented in the UK
Peto, J., Gilham, C., Fletcher, O., & Matthews, F. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16674-9 · Cited by 808
Lăără, E., Day, N., & Hakama, M. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92695-x · Cited by 657
Cuzick, J., Arbyn, M., Sankaranarayanan, R., Tsu, V., Ronco, G., Mayrand, M.-H., Dillner, J., & Meijer, C. J. L. M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.019 · Cited by 636
Challenges to effective cancer control in China, India, and Russia
Goss, P. E., Strasser-Weippl, K., Lee-Bychkovsky, B. L., Fan, L., Li, J., Chavarri-Guerra, Y., Liedke, P. E. R., Pramesh, C. S., Badovinac-Crnjevic, T., Sheikine, Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70029-4 · Cited by 496
Interventions targeted at women to encourage the uptake of cervical screening
Everett, T., Bryant, A., Griffin, M. F., Martin-Hirsch, P. P., Forbes, C. A., & Jepson, R. G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002834.pub2 · Cited by 332
Benefit of cervical screening at different ages: evidence from the UK audit of screening histories
Sasieni, P., Adams, J., & Cuzick, J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600974 · Cited by 332
Risk of cancer in women receiving hormone replacement therapy
Adami, H., Persson, I., Hoover, R., Schairer, C., & Bergkvist, L. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440515 · Cited by 267
Denny, L., de Sanjose, S., Mutebi, M., Anderson, B. O., Kim, J., Jeronimo, J., Herrero, R., Yeates, K., Ginsburg, O., & Sankaranarayanan, R. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31795-0 · Cited by 246
Human Papillomavirus and the Long-term Risk of Cervical Neoplasia
van der Graaf, Y. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf013 · Cited by 96
Human papilloma virus, papanicolaou smears, and the college female
Moscicki, A.-B. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2004.10.005 · Cited by 24
Metadata
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1986-09-13
- Volume
- 293
- Issue
- 6548
- Pages
- 659-664
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W4241179867
- Cited by
- 378
- References
- 5
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.